mantle cell lymphoma - Globe Thesis

Keyword [mantle cell lymphoma] Result: 21 - 40 \| Page: 2 of 5
21.	Chimeric Antigen Receptor-modified T Cells Against Blood Malignant Tumor
22.	The Role Of MIR-548m/CDK6 In The Pathogenesis Of Mantle Cell Lymphoma
23.	Effects Of CAL-101 In Combination With BTZ On Mantle Lymophma Cells And Exploration Of Its Relative Mechanism
24.	SOXâ…¡Protein Expression And Prognosis Of Mantle Cell Lymphoma
25.	Analysis Prognosis Related Factors Of 18 Patients Of Mantle Cell Lymphoma
26.	Clinicalcharacteristics And Prognostic Analysis Of 44 Cases With Mantle Cell Lymphoma (MCL)
27.	Fluorescence In Situ Hybridization Detection Cytogenetics The Relationship Between The Prognosis Of Patients Within MCL
28.	The Efficacy Of Rituximab With Conventional Chemotherapy In Mantle Cell Lymphoma:A Systematic Review
29.	Study Of Antitumor Effects Of KLF4 And ATO In Mantle Cell Lymphoma Through Targeting Wnt Signaling Pathway
30.	A Study Of The Relationship Of SOX11mRNA,miR-155-5p,miR-34a And P53 Gene Variation,Clinical Pathology Characteristics And Prognostic Significance In Mantle Cell Lymphoma
31.	The Affect Of Phosphatidylinositol 3-kinase Inhibitor LY294002 On Cell Proliferation And Chemotherapy In Mantle Cell Lymphoma
32.	Expression Of PTEN And PI3K/Akt/mTOR Signal Pathway In Mantle Cell Lymphoma
33.	Clinical Features And Prognostic Analysis In Mantle Cell Lymphoma
34.	The Effection Of Decitabine Combined With Brotezomib On Proliferation And Apoptosis In Human Mantle Cell Lymphoma Cells And Related Mechanism
35.	The Effection Of Chidamide Combinded With Bortezomib On The Proliferation And Apoptosis In Human Mantle Cell Lymphoma Cells And Related Mechanism
36.	Clinical Features,Treatment Protocols And Prognostic Factors Of 83 Cases Of Mantle Cell Lymphoma
37.	Study On The Role And Mechanism Of The Second Generation HSP90 Inhibitor(Ganetespib)in The Treatment Of Mantle Cell Lymphoma
38.	Studies On The Clinical Significance Of BTK Expression And Synergistic Anti-tumor Effect Of BTK Inhibitor BGB-3111 Combinated With Bortezomib In Mantle Cell Lymphoma
39.	Analysis Of Clinicopathologic Characteristics、Treatment And Prognosis Of Patients With Mantle Cell Lymphoma
40.	Deguelin Inhibited Cell Growth By PI3K/Akt Pathway In Mantle Cell Lymphoma
<<First <Prev Next> Last>> Jump to